Elizabeth Lovelace

1.4k citations
18 papers · 1.2k indexed · h-index 14
Topics
Virus-based gene therapy research (4 papers)Drug Transport and Resistance Mechanisms (4 papers)Adenosine and Purinergic Signaling (3 papers)

In The Last Decade

Elizabeth Lovelace

18 papers receiving 1.2k citations

Peers

Elizabeth Lovelace
Comparison fields: 5 of 85
  • Molecular Biology 616
  • Oncology 594
  • Genetics 153
  • Pediatrics, Perinatology and Child Health 150
  • Epidemiology 141
Replace Raymond M. Baker with:
Raymond M. Baker United States
N Rosen United States
Alain Devault France
D. Parker Suttle United States
J. G. Holland United States
Marianne S. Poruchynsky United States
Benjamin T. Vroman United States
Roberta C. Reuben United States
Ming Chu United States
James R. Zucali United States
Elizabeth Lovelace relative to Raymond M. Baker United States Raymond M. Baker's profile →
Citations per field
00.5×10×17×
Raymond M. Baker · 1×
Citations per year

Countries citing papers authored by Elizabeth Lovelace

Since Specialization
Citations

This map shows the geographic impact of Elizabeth Lovelace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Lovelace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Lovelace more than expected).

Fields of papers citing papers by Elizabeth Lovelace

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Lovelace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Lovelace. The network helps show where Elizabeth Lovelace may publish in the future.

Co-authorship network of co-authors of Elizabeth Lovelace

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Lovelace. A scholar is included among the top collaborators of Elizabeth Lovelace based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Lovelace. Elizabeth Lovelace is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 12
2 50
3 28
4 80
5
Characterization of monoclonal antibodies B1 and B3 that react with mucinous adenocarcinomas.
128
6 3
7 427
8 41
9 46
10 15
11 44
12 105
13 63
14 31
15 131
16
Burkitt tumor: brain lesions in hamsters induced with an extract from the SL-1 cell line.
3
17 32
18
Viruses in cultures of human leukemia cells.
2

About Elizabeth Lovelace

Elizabeth Lovelace is a scholar working on Physiology, Genetics and Virology, having authored 18 papers that have together received 1.2k indexed citations. Recurring topics across this work include Virus-based gene therapy research (4 papers), Drug Transport and Resistance Mechanisms (4 papers) and Adenosine and Purinergic Signaling (3 papers). The work is most often cited by research in Oncology (594 citations), Molecular Biology (616 citations) and Physiology (36 citations). Elizabeth Lovelace has collaborated with scholars based in United States, India and Malaysia. Frequent co-authors include Ira Pastan, A V Rutherford, Michael M. Gottesman, Mark C. Willingham, Kazumitsu Ueda, Sarah E. Stewart, Maria Gallo, P Thomopoulos, JACQUELINE WHANG and V. A. Ngu. Their work appears in journals such as Science, Cell and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026